Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture ...Middle East

PR Newswire - News
Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture
SINGAPORE, June 25, 2021 /PRNewswire/ -- CYFIRMA, a threat discovery and cyber-intelligence platform company, funded by Goldman Sachs, Zodius Capital and Z3Partners, today announced that Zuellig Pharma, a leading healthcare services provider in Asia, has selected DeCYFIR, a cloud-based,...

Hence then, the article about zuellig pharma selects cyfirma to elevate cyber intelligence capabilities and strengthen cybersecurity posture was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Zuellig Pharma Selects CYFIRMA to Elevate Cyber-intelligence Capabilities and Strengthen Cybersecurity Posture )

Apple Storegoogle play

Last updated :

Also on site :



Latest News